Some discomfort at the injection site is common, but if the pain, swelling, redness persist for long or aggravate, then a doctor should be consulted
the current Egrifta SV formulation (FDA 2019) reduces the daily dose to 1.4 mg/day SC
These associations are most useful when corroborating findings are present, so the rest of the workup, not the B12 alone, determines how far to go
In contrast to the IVW approach which sets the intercept term to zero, the introduction of the aforementioned parameter in the MR-Egger framework enables assessment of pleiotropic effects that may be distributed independently from those of instrumental variables (IVs) on outcomes through exposures
Peptides and peptide-based biomaterials and their biomedical applications
None of those interventions is Dihexa